Biodistribution of Drug/ADA Complexes: The Impact of Immune Complex Formation on Antibody Distribution
Eugenia Opolka-Hoffmann(Roche (Switzerland)), Roland F. Staack(Roche Pharma AG (Germany)), Simon Hauri(Roche (Switzerland)), Gregor Jordan(Roche Pharma AG (Germany)), Michael B. Otteneder(Roche (Switzerland)), Peter Schrag(Roche (Switzerland)), Martin R. Edelmann(Roche (Switzerland)), Gerhard Winter(University of New England), Martin Lechmann(Roche (Switzerland))
Cited by 7
Related Papers
Immunization with hepatitis C virus-like particles protects mice from recombinant hepatitis C virus-vaccinia infection
|Proceedings of the National Academy of Sciences|2003|170
Matrix-loaded biodegradable gelatin nanoparticles as new approach to improve drug loading and delivery
|European Journal of Pharmaceutics and Biopharmaceutics|2010|151
Immunopurification and Mass Spectrometric Quantification of the Active Form of a Chimeric Therapeutic Antibody in Human Serum
|Analytical Chemistry|2008|144
Vaccination trial with HPV16 L1E7 chimeric virus‐like particles in women suffering from high grade cervical intraepithelial neoplasia (CIN 2/3)
|International Journal of Cancer|2007|136